A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

THE Department of Science and Technology (DOST) is set to strengthen its research and development (R&D) initiatives for 2025, focusing primarily on industrial technology and biotechnology.

Hutchmed divests 45% equity in SHPL for $608M, retaining 5%. Net income from SHPL in 2023 was $47.4 million. China NMPA grants priority review for Orpathys-Tagrisso combo in advanced positive lung ...

An international research team led by the University of California, Irvine has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue ...

Shareholders of the private biotech could also receive a potential payment tied to an undisclosed development milestone. Madison, Wisconsin-based Nimble’s lead asset is a preclinical IL23R ...

WESTPORT, Conn., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel ...

A global biotech firm that develops novel cancer treatments wants to build a facility in NeoCity for its future offices, research and development, and manufacturing. Empyrean, which is based in ...

A road in a west Suffolk town has been closed after two cars collided near a cycle path. Suffolk police are attending the scene on Mount Road after there were reports of a crash just before 2 ...

SAN FRANCISCO, December 18, 2024--(BUSINESS WIRE)--Vir Biotechnology Inc. (NASDAQ: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive ...

SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company ...